In experimental NEC, EPO protects the intestinal epithelium by diminishing excessive autophagy via the Akt/ mechanistic target of rapamycin (mTOR) signaling pathway and by upregulating B-Cell Lymphoma gene 2 (Bcl-2) via the MAPK/ERK pathway to reduce apoptosis [90]. This evidence concerns the gene EPO and necrotizing enterocolitis.